BBP vs. HELX ETF Comparison
Comparison of BioShares Biotechnology Products Fund (BBP) to Franklin Genomic Advancements ETF (HELX)
BBP
BioShares Biotechnology Products Fund
BBP Description
The BioShares Biotechnology Products Fund (BBP) seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index.
Grade (RS Rating)
Last Trade
$64.41
Average Daily Volume
875
Number of Holdings
*
60
* may have additional holdings in another (foreign) market
HELX
Franklin Genomic Advancements ETF
HELX Description
Seeks capital appreciation by investing in innovative companies related to genomic-based technologies designed to enhance the quality of life. Provides access to companies benefitting from or facilitating the use of new research including DNA sequencing, gene editing and personalized medicine Uses bottom-up fundamental research conducted by dedicated, industry-specific analysts to identify disruptive business models at the right stage for investment Actively managed by a seasoned portfolio management team that is based in Silicon Valley and has a long history of investing in the craft of innovationGrade (RS Rating)
Last Trade
$30.51
Average Daily Volume
1,729
Number of Holdings
*
51
* may have additional holdings in another (foreign) market
Performance
Period | BBP | HELX |
---|---|---|
30 Days | 2.52% | -4.73% |
60 Days | 0.39% | -8.33% |
90 Days | 6.39% | -6.94% |
12 Months | 35.21% | 16.57% |
17 Overlapping Holdings
Symbol | Grade | Weight in BBP | Weight in HELX | Overlap | |
---|---|---|---|---|---|
ALNY | C | 2.72% | 1.99% | 1.99% | |
BBIO | D | 1.24% | 0.92% | 0.92% | |
BMRN | F | 1.24% | 0.2% | 0.2% | |
BNTX | B | 1.73% | 1.85% | 1.73% | |
CRSP | C | 1.09% | 0.65% | 0.65% | |
DVAX | A | 1.33% | 0.2% | 0.2% | |
INSM | D | 1.73% | 2.11% | 1.73% | |
IONS | F | 1.4% | 2.05% | 1.4% | |
KRYS | C | 1.42% | 4.25% | 1.42% | |
LGND | A | 2.03% | 0.88% | 0.88% | |
MRNA | F | 0.54% | 0.79% | 0.54% | |
NBIX | C | 1.26% | 0.84% | 0.84% | |
RARE | D | 1.89% | 1.46% | 1.46% | |
REGN | F | 1.34% | 5.0% | 1.34% | |
SRPT | D | 1.57% | 1.56% | 1.56% | |
UTHR | A | 1.81% | 1.86% | 1.81% | |
VRTX | D | 1.46% | 5.79% | 1.46% |
BBP Overweight 43 Positions Relative to HELX
Symbol | Grade | Weight | |
---|---|---|---|
TVTX | B | 3.71% | |
ZLAB | B | 2.5% | |
PHAT | B | 2.2% | |
ADMA | B | 2.2% | |
MIRM | B | 2.19% | |
GILD | A | 2.07% | |
TGTX | A | 2.06% | |
BCRX | A | 1.95% | |
AUPH | A | 1.95% | |
BGNE | C | 1.91% | |
EXEL | A | 1.9% | |
IOVA | B | 1.86% | |
AXSM | C | 1.82% | |
YMAB | A | 1.8% | |
TARS | A | 1.74% | |
HRMY | D | 1.7% | |
PTCT | B | 1.67% | |
DAWN | A | 1.66% | |
RYTM | D | 1.66% | |
FOLD | B | 1.64% | |
ITCI | A | 1.64% | |
ROIV | D | 1.62% | |
AMGN | C | 1.57% | |
INCY | A | 1.54% | |
ASND | F | 1.51% | |
LEGN | F | 1.5% | |
LXRX | D | 1.49% | |
TBPH | C | 1.49% | |
HALO | B | 1.47% | |
AGIO | B | 1.43% | |
ACAD | F | 1.42% | |
ARDX | D | 1.34% | |
IMCR | F | 1.22% | |
GERN | C | 1.22% | |
BIIB | F | 1.17% | |
BPMC | C | 1.16% | |
SWTX | D | 1.1% | |
MDGL | A | 1.09% | |
ESPR | C | 1.05% | |
SAGE | F | 1.01% | |
IRWD | F | 0.99% | |
NVAX | F | 0.98% | |
APLS | F | 0.96% |
BBP Underweight 34 Positions Relative to HELX
Symbol | Grade | Weight | |
---|---|---|---|
MEDP | F | -5.91% | |
DHR | D | -5.27% | |
LLY | F | -4.97% | |
TMO | D | -4.96% | |
NTRA | B | -3.8% | |
AZN | F | -2.68% | |
CTVA | A | -2.27% | |
A | D | -2.08% | |
BRKR | D | -2.01% | |
CDNS | C | -1.98% | |
CRL | F | -1.95% | |
QGEN | D | -1.85% | |
EXAS | A | -1.73% | |
ICLR | F | -1.66% | |
RCKT | F | -1.57% | |
RVTY | C | -1.48% | |
TWST | F | -1.22% | |
IQV | F | -1.13% | |
VYGR | C | -1.11% | |
LH | A | -0.97% | |
TECH | B | -0.91% | |
AZTA | F | -0.86% | |
BEAM | F | -0.86% | |
NTLA | F | -0.83% | |
CDMO | C | -0.8% | |
RXRX | F | -0.57% | |
RGEN | D | -0.54% | |
BIO | A | -0.53% | |
AVTR | F | -0.5% | |
FDMT | F | -0.44% | |
BMY | A | -0.31% | |
SLP | F | -0.3% | |
VCYT | A | -0.24% | |
ARE | F | -0.16% |
BBP: Top Represented Industries & Keywords
HELX: Top Represented Industries & Keywords